Overview

ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Comparison of clinical efficacy and safety of levocetirizine in PER continuous versus on demand, measured by evolution of individual symptom scores during 6 months.
Phase:
Phase 4
Details
Lead Sponsor:
UCB Pharma
UCB S.A. - Pharma Sector
Treatments:
Cetirizine
Levocetirizine